Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent.
Adolescents infected with the human immunodeficiency virus (HIV) often confront the clinician with difficult medical problems. Besides the host of opportunistic infections, which can affect these patients, side effects from medications can be frequent and, at times, life-threatening. We report a case of aseptic meningitis secondary to trimethoprim-sulfamethoxazole therapy for prophylaxis against Pneumocystis carinii in an HIV-infected adolescent.
Rudy
B J
BJ
Division of General Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine 19140, USA.
Rutstein
R
R
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000293:Adolescent; D000890:Anti-Infective Agents / Q000009:adverse effects*; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008297:Male; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000150:complications*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination